( 12 ) United States Patent

( 12 ) United States Patent

US010206957B2 (12 ) United States Patent (10 ) Patent No. : US 10 , 206 , 957 B2 Myles et al . (45 ) Date of Patent: Feb . 19, 2019 ( 54 ) USE OF GRAM NEGATIVE SPECIES TO 6 ,974 ,585 B2 12 /2005 Askill 9 , 173 ,910 B2 11 /2015 Kaplan et al. TREAT ATOPIC DERMATITIS 2017 /0202889 AL 7 / 2017 Lang et al. (71 ) Applicant : THE UNITED STATES OF AMERICA , AS REPRESENTED BY FOREIGN PATENT DOCUMENTS THE SECRETARY , DEPARTMENT EP 1786445 A2 5 /2007 OF HEALTH AND HUMAN WO WO - 9510999 AL 4 / 1995 SERVICES, NATIONAL INSTITUTE WO WO - 03047533 A2 6 / 2003 OF HEALTH , Washington , DC (US ) WO WO - 2006048747 A1 5 / 2006 Wo WO - 2012150269 AL 11 / 2012 (72 ) Inventors: Ian Antheni Myles , Bethesda, MD WO WO - 2017184601 A1 10 /2017 (US ) ; Sandip K . Datta , Bethesda, MD (US ) OTHER PUBLICATIONS (73 ) Assignee : THE UNITED STATES OF Asher et al. Worldwide time trends in the prevalence of symptoms AMERICA , AS REPRESENTED BY of asthma , allergic rhinoconjunctivitis , and eczema in childhood : THE SECRETARY, DEPARTMENT ISAAC Phases One and Three repeat multicountry cross- sectional OF HEALTH AND HUMAN surveys . Lancet 368 : 733 - 743 (2006 ) . SERVICES , Washington , DC (US ) Avis . Chapter 87 : Parenteral Preparations. Remington : The Science and Practice of Pharmacy, 19th Ed . (Easton , PA : Mack Publishing Co . ) (p . 1530 ) ( 1995 ) . ( * ) Notice : Subject to any disclaimer , the term of this Bantz et al. The Atopic March : Progression from Atopic Dermatitis patent is extended or adjusted under 35 to Allergic Rhinitis and Asthma. J Clin Cell Immunol 5 ( 2 ) :202 U . S . C . 154 ( b ) by 0 days . ( 2014 ) . Barnes et al . An update on the genetics of atopic dermatitis : (21 ) Appl. No. : 16 /014 ,971 scratching the surface in 2009 . J Allergy Clin Immunol 125 : 16 - 31 ( 2010 ) . (22 ) Filed : Jun . 21, 2018 Bilal et al . Pattern of Bacterial Colonization of Atopic Dermatitis in Saudi Children . J Clin Diagn Res . 7 ( 9 ) : 1968 - 1970 ( 2013 ) . ( 65 ) Prior Publication Data Bin et al. Genetic and epigenetic studies of atopic dermatitis . US 2018 /0296612 A1 Oct. 18 , 2018 Allergy Asthma Clin Immunol 12 : 52 ( 2016 ) . Bogdanffy et al .Metabolism of Dibasic Esters by Rat Natal Mucosal Related U . S . Application Data Carboxylesterase . Drug Metab Dispos 19 ( 1 ) : 124 - 129 ( 1991) . Boguniewicz et al . Recent insights into atopic dermatitis and (60 ) Division of application No . 15 / 939, 066 , filed on Mar. implications for management of infectious complications. J Allergy 28 , 2018 , which is a continuation of application No . Clin Immunol 125 ( 1 ) : 4 - 19 ( 2010 ) . PCT/ US2017 /028133 , filed on Apr. 18 , 2017 . Boguniewicz et al . The ABC ' s of managing patients with severe atopic dermatitis . J Allergy Clin Immunol 132 ( 2 ) :511 - 2 .e5 ( 2013 ). (60 ) Provisional application No . 62 /324 ,762 , filed on Apr. Brauweiler et al . The cytokines increase Staphylococcus aureus 19 , 2016 . alpha toxin - induced keratinocyte death through the signal trans ducer and activator of transcription 6 ( STAT6 ) . J Invest Dermatol (51 ) Int. Ci. 134 ( 8 ) :2114 -2121 ( 2014 ). A61K 35 /66 ( 2015 .01 ) Co -pending U . S . Appl. No . 15/ 939 ,066 , filed Mar. 28, 2018 . A61K 35 / 74 ( 2015 . 01 ) Czarnowicki et al. Novel concepts of prevention and treatment of A61P 17 /04 ( 2006 . 01 ) atopic dermatitis through barrier and immune manipulations with A61K 9 / 00 ( 2006 .01 ) implications for the atopic march . JAllergy Clin Immunol 139 ( 6 ) : 1723 A61K 9 / 06 ( 2006 .01 ) 1734 ( 2017 ) . ( 52 ) U . S . CI. Dé et al . Clinical significance of Roseomonas species isolated from CPC . .. .. .. A61K 35 / 74 ( 2013 .01 ) ; A61K 9 /0014 catheter and blood samples : analysis of 36 cases in patients with ( 2013 .01 ) ; A61K 9 / 06 ( 2013 .01 ) ; A61P 17 /04 cancer. Clin Infect Dis 38 ( 11) : 1579 - 1584 (2004 ) . (2018 .01 ) (Continued ) (58 ) Field of Classification Search CPC .. A61K 35 / 74 ; A61K 9 / 0014 ; A61P 17/ 04 Primary Examiner — Satyendra K Singh See application file for complete search history . ( 74 ) Attorney , Agent, or Firm — Wilson Sonsini Goodrich & Rosati ( 56 ) References Cited (57 ) ABSTRACT U . S . PATENT DOCUMENTS Pharmaceutical compositions are disclosed that includes a 3 , 832 , 253 A 8 / 1974 Di Palma et al . therapeutically effective amount of a purified viable gram 3 , 854 ,480 A 12 / 1974 Zaffaroni negative bacteria and a pharmaceutically acceptable carrier. 4 ,452 , 775 A 6 / 1984 Kent The pharmaceutical compositions are formulated for topical 4 ,667 , 014 A 5 / 1987 Nestor, Jr. et al . 4 , 748 , 034 A 5 / 1988 De Rham administration . Methods of treating atopic dermatitis using 4 ,829 ,000 A 5 / 1989 Kleinman et al . these pharmaceutical compositions are also disclosed . 5 , 239 ,660 A 8 / 1993 Ooi 6 ,218 , 371 B1 4 /2001 Krieg et al. 13 Claims, 11 Drawing Sheets US 10 ,206 ,957 B2 Page 2 (56 ) References Cited Latvala et al. Trends in prevalence of asthma and allergy in Finnish young men : nationwide study, 1966 -2003 . BMJ 330 (7501 ) : 1186 1187 ( 2005 ) . OTHER PUBLICATIONS Lau et al. A rapid matrix - assisted laser desorption ionization - time of flight mass spectrometry - based method for single -plasmid tracking Di Nardo et al . Ceramide and cholesterol composition of the skin of in an outbreak of carbapenem - resistant Enterobacteriaceae . J Clin patients with atopic dermatitis . Acta Derm Venereol 78 ( 1 ) : 27 - 30 Microbiol 52 : 2804 - 2812 (2014 ) . ( 1998 ) . Lau et al. Development of a clinically comprehensive database and Dinulos et al. New science and treatment paradigms for atopic a simple procedure for identification of molds from solid media by dermatitis . Curr Opin Pediatr 30 ( 1 ) : 161 - 168 (2018 ) . matrix -assisted laser desorption ionization - time of flight mass spec Dolgin . First eczema biologic debuts but price could restrict use . trometry . J Clin Microbiol 51 :828 - 834 ( 2013 ) . Nat Biotechnol 35 ( 5 ) :391 -392 ( 2017 ) . Leloup et al . Outpatient Home- based Wet Wrap Dressings with Dréno et al. Microbiome in healthy skin , update for dermatologists . Topical Steroids with Children with Severe Recalcitrant Atopic J Eur Acad Dermatol Venereol 30 ( 12 ) :2038 - 2047 ( 2016 ) . Dermatitis : A Feasibility Pilot Study. Pediatr Dermatol 32 ( 4 ) :e177 Eichenfield et al . Current guidelines for the evaluation and man 178 (2015 ) . agement of atopic dermatitis : A comparison of the Joint Task Force Lewis - Jones . Quality of life and childhood atopic dermatitis : the Practice Parameter and American Academy of Dermatology guide misery of living with childhood eczema. Int J Clin Pract 60 ( 8 ): 984 lines . J Allergy Clin Immunol 139 (45 ) : S49 - S57 ( 2017 ) . 992 ( 2006 ) . Eichenfield et al. Guidelines of Care for the Management of Atopic Li et al. Altered composition of epidermal lipids correlates with Dermatitis : Part 2 : Management and Treatment of Atopic Dermatitis Staphylococcus aureus colonization status in atopic dermatitis . Br J with Topical Therapies . J Am Acad Dermatol 71 ( 1 ) : 116 - 132 (2014 ) . Dermatol 177 ( 4 ) :e125 - e127 (2017 ) . Follin et al. A skin chamber technique as a human model for studies Li et al . Topical vitamin D3 and low - calcemic analogs induce of aseptic inflammatory reactions. Method Mol Biol 412 : 333 -346 thymic stromal lymphopoietin in mouse keratinocytes and trigger an ( 2007 ) . atopic dermatitis . PNAS USA 103 ( 31 ) : 11736 - 11741 ( 2006 ) . Gerding et al. Administration of Spores of Nontoxigenic Clostridium Lyons et al. Atopic dermatitis in children : clinical features , pathophysiol difficile Strain M3 for Prevention of Recurrent C difficile Infection : ogy , and treatment . Immunol Allergy Clin North Am 35 : 161 - 183 A Randomized Clinical Trial. JAMA 313 ( 17 ) : 1719 - 1727 (2015 ) . ( 2015 ) . Gittler et al . Bathing and Associated Treatment in Atopic Derma Margolis et al . Persistence of mild to moderate atopic dermatitis . titis . Am J Clin Dermatol 18 : 45 -57 ( 2017 ) . JAMA Dermatol . 150 (6 ) :593 -600 ( 2014 ) . Grice et al. The Skin Microbiome. Nature 9 : 244 -253 (2011 ) . Mennini et al. Two Phase 3 Trials of Dupilumab versus Placebo in Gueniche et al . Effects of nonpathogenic gram -negative bacterium Atopic Dermatitis . N Engl J Med 376 ( 11 ) : 1090 ( 2017 ) . Vitreoscilla filiformis lysate on atopic dermatitis : a prospective , Michon et al. Bacteremia due to imipenem -resistant Roseomonas randomized , double -blind , placebo -controlled clinical study . Br J mucosa in a child with acute lymphoblastic leukemia . J Pediatr Dermatol 159 : 1357 - 1363 ( 2008 ) . Hematol Oncol. 36 ( 3 ) :e165 - 168 ( 2014 ) . Henderson et al. The burden of disease associated with filaggrin Miller et al . Vitamin D and innate immunity . Dermatol Ther mutations : A population -based , longitudinal birth cohort study . J 23 : 13 - 22 ( 2010 ) . Allergy Clin Immunol 121( 4 ) : 872 - 877 .e9 ( 2008 ) . Miyamoto - Shinohara et al. Survival of freeze - dried bacteria . J Gen Hon et al . Barrier repair therapy in atopic dermatitis : an overview . Appl Microbiol 54 ( 1 ) : 9 -24 ( 2008 ) . Am J Clin Dermatol 14 ( 5 ) :389 - 399 ( 2013 ) . Msika et al . New emollient with topical corticosteroid - sparing effect Hsu et al . Intermediate phenotypes in patients with autosomal in treatment of childhood atopic dermatitis : SCORAD and quality dominant hyper - IgE syndrome caused by somatic mosaicism . J of life improvement. Pediatr Dermatol 25 ( 6 ) :606 -612 (2008 ) . Allergy Clin Immunol 131 (6 ) : 1586 - 1593 ( 2013 ) . Muthuri et al . Impact of neuraminidase

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    29 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us